| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncocyte Corp | CEO and President, Director | Common Stock, no par value | 3.51K | $10.3K | $2.95 | Apr 11, 2024 | Direct |
| Oncocyte Corp | CEO and President, Director | Option to Purchase Common Stock | 90K | May 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OCX | Oncocyte Corp | May 20, 2024 | 1 | $0 | 4 | May 22, 2024 | CEO and President, Director |
| OCX | Oncocyte Corp | Apr 11, 2024 | 1 | $10K | 4 | Apr 15, 2024 | CEO and President, Director |
| OCX | Oncocyte Corp | Aug 15, 2023 | 1 | $0 | 4 | Aug 17, 2023 | CEO and President, Director |
| OCX | Oncocyte Corp | Jun 9, 2023 | 2 | $0 | 4 | Jun 13, 2023 | CEO and President, Director |
| OCX | Oncocyte Corp | Feb 24, 2023 | 1 | $0 | 4 | Feb 28, 2023 | CEO |
| OCX | Oncocyte Corp | Jan 17, 2023 | 1 | $0 | 4 | Jan 19, 2023 | Interim CEO |
| OCX | Oncocyte Corp | Dec 2, 2022 | 0 | $0 | 3 | Dec 9, 2022 | Interim CEO |